% IMPORTANT: The following is UTF-8 encoded. This means that in the presence
% of non-ASCII characters, it will not work with BibTeX 0.99 or older.
% Instead, you should use an up-to-date BibTeX implementation like “bibtex8” or
% “biber”.
@ARTICLE{Ola:302118,
author = {I. Ola$^*$ and R. Cardoso$^*$ and M. Hoffmeister$^*$ and H.
Brenner$^*$},
title = {{R}ecent trends in self-reported utilization of colonoscopy
and fecal occult blood test in {E}urope: analysis of the
{E}uropean {H}ealth {I}nterview {S}urveys 2013-2015 and
2018-2020.},
journal = {European journal of epidemiology},
volume = {40},
issn = {0393-2990},
address = {[Cham]},
publisher = {Springer Nature Switzerland AG},
reportid = {DKFZ-2025-01250},
pages = {767–778},
year = {2025},
note = {#EA:C070#LA:C070# / Volume 40, pages 767–778},
abstract = {Despite increasing implementation of colorectal cancer
(CRC) screening programs in Europe, utilization of screening
tests has varied significantly over the years. We examined
recent trends in the utilization of colonoscopy and fecal
occult blood test (FOBT), the primary tests recommended for
CRC screening, across European countries with various
screening programs. Population-based data from the second
and third waves of the European Health Interview Survey
(EHIS) were analyzed to determine changes in utilization of
fecal occult blood test within the preceding 2 years or
colonoscopy within the preceding 10 years among people aged
50-74 years between 2013-2015 and 2018-2020. Absolute
percentage changes (APC) in screening test use were
calculated in each country and subgroup meta-analyses were
conducted using random effects models to estimate the pooled
APCs and their $95\%$ confidence intervals across different
categories of screening offers. A total of 234,251
respondents across 28 European countries were included in
the analysis. The increase in use of either test was highest
among countries which fully rolled out nationwide organized
screening programs with fecal tests between 2013-2015 and
2018-2020 (increases ranging from $19.1\%$ units in Belgium
to $46.3\%$ units in The Netherlands) and was lowest among
countries with opportunistic offering of fecal test,
colonoscopy or flexible sigmoidoscopy (from - $3\%$ units in
Germany to + $12.2\%$ units in Slovakia). Changes in
screening programs were strongly associated with higher
rates of utilization of colonoscopy and fecal occult blood
test across all screening offers. Our findings highlight
that well-organized and dynamic population screening
strategies can rapidly and sustainably increase utilization
of CRC screening tests in Europe.},
keywords = {Cancer prevention and control (Other) / Cancer screening
(Other) / Colonoscopy (Other) / Colorectal cancer (Other) /
Fecal occult blood test (Other) / Utilization trends
(Other)},
cin = {C070 / HD01},
ddc = {610},
cid = {I:(DE-He78)C070-20160331 / I:(DE-He78)HD01-20160331},
pnm = {313 - Krebsrisikofaktoren und Prävention (POF4-313)},
pid = {G:(DE-HGF)POF4-313},
typ = {PUB:(DE-HGF)16},
pubmed = {pmid:40526328},
doi = {10.1007/s10654-025-01247-4},
url = {https://inrepo02.dkfz.de/record/302118},
}